Effects of tumor types on treatment strategy formulation and prognostic evaluation of gastric neuroendocrine tumors.

The effects of different types of gastric neuroendocrine tumors (G-NETs) on treatment strategy formulation and prognostic evaluation still remain controversial due to their rarity. 187 patients diagnosed with G-NETs were subdivided into four types based on the pathophysiology, etiology and presentation. Type I, II G-NETs >1.0 cm and type III, IV G-NETs >2.0 cm are proved with aggressive behavior (p < 0.05). Type III G-NETs with higher Ki-67 index and tumor stage showed more invasive potential than type I and II G-NETs (p < 0.05). Endoscopic resection is the primary treatment for type I, II G-NETs, while surgical combined with chemotherapy is associated with favorable outcomes for type IV G-NETs. The clinical classifications of G-NETs are of great significance for the choice of treatment and the evaluation of prognosis.